Phase III clinical trial comparing immunogenicity and safety of liquid Rotavin vaccine vs. licensed frozen Rotavin-M1 in healthy Vietnamese children.

PROJECT OVERVIEW

The study "Phase III clinical trial, randomized, partially double-blind, controlled to compare the immunogenicity and safety of the liquid form of Rotavin vaccine with the currently licensed frozen form (Rotavin-M1) in healthy children in Vietnam" was conducted starting in 2020 at the Vaccine and Medical Biological Products Research and Production Center (POLYVAC).

Research Details
  • TOPIC NAME Phase III clinical trial comparing immunogenicity and safety of liquid Rotavin vaccine vs. licensed frozen Rotavin-M1 in healthy Vietnamese children.
  • Chủ nhiệm đề tài PATH Organization and POLYVAC
  • Tên dự án Joint projects with domestic and international organizations
  • Chủ nhiệm dự án 2024

Project/Topic Results

Test results
  • Vắc xin Rotavin-M1 có thể bảo quản ở nhiệt độ 2 – 8°C, thuận tiện cho quá trình vận chuyển và bảo quản vắc xin